SEC Form 4 · accession 0001209191-15-060935
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ken Valenzano
Officer — SVP, Pharmacology & Biology
Period of report
Jul 13, 2015
Accepted (ET)
Jul 15, 2015 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jul 13, 2015 | M | 9,500 | $15.00 | A | 37,187 | D | |
| Common stock | Jul 13, 2015 | S | 9,500 | $15.00 | D | 27,687 | D | |
| Common stock | Jul 13, 2015 | M | 2,500 | $15.00 | A | 30,187 | D | |
| Common stock | Jul 13, 2015 | S | 2,500 | $15.00 | D | 27,687 | D | |
| Common stock | Jul 13, 2015 | M | 3,000 | $15.00 | A | 30,687 | D | |
| Common stock | Jul 13, 2015 | S | 3,000 | $15.00 | D | 27,687 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $5.325 | Jul 13, 2015 | M | 9,500 | D | Feb 1, 2010 | Feb 28, 2016 | Common Stock | 9,500 | 0 | D |
| Stock Options (right to buy) | $4.16 | Jul 13, 2015 | M | 2,500 | D | Nov 1, 2013 | Nov 16, 2019 | Common Stock | 2,500 | 20,000 | D |
| Stock Options (right to buy) | $4.38 | Jul 13, 2015 | M | 3,000 | D | Jun 1, 2016 | Jun 4, 2022 | Common Stock | 3,000 | 24,000 | D |
Explanation of responses
- F1The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2015.